SIROLIMUS vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. SIROLIMUS and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SIROLIMUS	SORAFENIB TOSYLATE
Rating	66/100	New
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	SORAFENIB TOSYLATE
Manufacturer	Apotex	Yabao Pharm
Dosage forms	Solution	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

sirolimus sorafenib tosylate

Rating

66/100

New

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

SORAFENIB TOSYLATE

Manufacturer

Apotex

Yabao Pharm

Dosage forms

Solution

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Sirolimus and Sorafenib Tosylate?

Sirolimus contains Sirolimus, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.